Papers - SAKAI Akira
-
東日本大震災から学ぶ内科疾患～特徴，対応，予防～6)放射線災害と内科学
大津留晶，緑川早苗，志村浩己，坂井晃
日本内科学会雑誌 103 ( 3 ) 581 - 587 2014
-
悪性リンパ腫における血清中可溶性インターロイキン２レセプター（sIL-2R）に対する腫瘍関連マクロファージの役割
坂井晃，吉田稚明
福島医学雑誌 64 ( 2 ) 67 - 75 2014
-
多発性骨髄腫 Updating 第7巻 再発・難治多発性骨髄腫 -再発の定義と再発例の治療目標- VII 再発・難治多発性骨髄腫に対する第二世代の新規薬剤の効果 HDAC阻害剤 (2) Vorinostat
坂井晃
医薬ジャーナル社 7 176 - 183 2014
-
Life as an evacuee after the Fukushima Daiichi Nuclear Power Plant accident is a cause of polycythemia: The Fukushima Health Management Survey
Sakai A, Ohira T, Hosoya M, Ohtsuru A, Satoh H, Kawasaki Y, Suzuki H, Takahashi A, Kobashi G, Ozasa K, Yasumura S, Yamashita S, Kamiya K, Abe M, for the Fukushima Health Management Survey Group
BMC Public Health 14 1318 2014
-
Vertebral Fracture Risk of Multiple Myeloma Assessed by a CT-based Finite Element and Trabecular Structure Analysis.
Miyuki Takasu, Yoko Kaichi, Kazuo Awai, Hideki Asaoku, Yoshiaki Kuroda, Akira Sakai
Clinical Lymphoma Myeloma and Leukemia 14 ( 1 ) 12 - 13 2014
-
Vertebral Fracture Risk of Multiple Myeloma Assessed by a CT-based Finite Element and Trabecular Structure Analysis.
Miyuki Takasu, Yoko Kaichi, Kazuo Awai, Hideki Asaoku, Yoshiaki Kuroda, Akira Sakai
Clinical Lymphoma Myeloma and Leukemia 14 ( 1 ) 12 - 13 2014
-
The role of tumor-associated macrophages on serum soluble IL-2R level in B-cell lymphomas.
Akira Sakai, Noriaki Yoshida
Journal of Clinical and Experimental Hematopathology ( 54 ) 49 - 57 2014
-
The role of tumor-associated macrophages on serum soluble IL-2R level in B-cell lymphomas.
Akira Sakai, Noriaki Yoshida
Journal of Clinical and Experimental Hematopathology ( 54 ) 49 - 57 2014
-
The role of tumor-associated macrophages on serum soluble IL-2R level in B-cell lymphomas.
Sakai A, Yoshida N
J Clin and Exp Hematop 54 49 - 57 2014
-
The role of tumor-associated macrophages on serum soluble IL-2R level in B-cell lymphomas.
Sakai A, Yoshida N
J Clin and Exp Hematop 54 49 - 57 2014
-
The Basic Data for residents aged 16 years or older who received a Comprehensive Health Check examinations in 2011-2012 as a part of the Fukushima Health Management Survey after the Great East Japan Earthquake
Kawasaki Y, Hosoya M, Yasumura S, Ohira T, Satoh H, Suzuki H, Sakai A, Ohtsuru A, Takahashi A, Ozasa K, Kobashi G, Kamiya K, Yamashita S, Abe M, and the Fukushima Health Management Survey Group
Fukushima J Med Sci 2014
-
The Basic Data for residents aged 16 years or older who received a Comprehensive Health Check examinations in 2011-2012 as a part of the Fukushima Health Management Survey after the Great East Japan Earthquake
Kawasaki Y, Hosoya M, Yasumura S, Ohira T, Satoh H, Suzuki H, Sakai A, Ohtsuru A, Takahashi A, Ozasa K, Kobashi G, Kamiya K, Yamashita S, Abe M, and the Fukushima Health Management Survey Group
Fukushima J Med Sci 2014
-
Over one third of African-American MGUS and multiple myeloma patients are carriers of hyperphosphorylated paratarg-7, an autosomal-dominantly inherited risk factor for MGUS/MM.
Carsten Zwick, Gerhard Held, Michaela Auth, Leon Bernal-Mizrachi, John D. Roback, Susan Sunay, Shinsuke Iida, Yoshiaki Kuroda, Akira Sakai, Marita Ziepert, Ryuzo Ueda, Michael Pfreundschuh, Klaus-Dieter Preuss
International Journal of Cancer 135 ( 4 ) 934 - 938 2014
-
Over one third of African-American MGUS and multiple myeloma patients are carriers of hyperphosphorylated paratarg-7, an autosomal-dominantly inherited risk factor for MGUS/MM.
Carsten Zwick, Gerhard Held, Michaela Auth, Leon Bernal-Mizrachi, John D. Roback, Susan Sunay, Shinsuke Iida, Yoshiaki Kuroda, Akira Sakai, Marita Ziepert, Ryuzo Ueda, Michael Pfreundschuh, Klaus-Dieter Preuss
International Journal of Cancer 135 ( 4 ) 934 - 938 2014
-
Over one third of African-American MGUS and multiple myeloma patients are carriers of hyperphosphorylated paratarg-7, an autosomal-dominantly inherited risk factor for MGUS/MM
Zwick C, Held G, Auth M, Bernal-Mizrachi L , Roback JD, Sunay S, Iida S, Kuroda Y, Sakai A, Ziepert M, Ueda R, Pfreundschuh M , Preuss KD
nt J Cancer 135 ( 4 ) 934 - 938 2014
-
Over one third of African-American MGUS and multiple myeloma patients are carriers of hyperphosphorylated paratarg-7, an autosomal-dominantly inherited risk factor for MGUS/MM
Zwick C, Held G, Auth M, Bernal-Mizrachi L , Roback JD, Sunay S, Iida S, Kuroda Y, Sakai A, Ziepert M, Ueda R, Pfreundschuh M , Preuss KD
nt J Cancer 135 ( 4 ) 934 - 938 2014
-
Magnetic resonance evaluation of multiple myeloma at 3.0 tesla: How do bone marrow plasma cell percentage and selection of protocols affect lesion conspicuity?
Takasu M, Tamura T, Kaichi Y, Tanitame K, Akiyama Y, Date S, Sakai A, Kuroda Y, Awai K
Plos One 9 ( 1 ) e85931 2014
-
悪性リンパ腫における血清中可溶性インターロイキン２レセプター（sIL-2R）に対する腫瘍関連マクロファージの役割
坂井晃, 吉田稚明
福島医学雑誌 64 ( 2 ) 67 - 75 2014
-
医学セミナー 2013
福田俊章, 石川和信, 藤野美都子, 坂井晃, 挾間章博, 岡田達也, 志村清仁
福島医学雑誌 64 ( 4 ) 211 - 212 2014
-
Clinical significance of sIL-2R levels in B-cell lymphomas
Yoshida N., Oda M., Kuroda Y., Katayama Y., Okikawa Y., Masunari T., Fujiwara M., Nishisaka T., Sasaki N., Sadahira Y., Mihara K., Asaoku H., Matsui H., Seto M., Kimura A., Arihiro K., Sakai A.
PLoS ONE 8 ( 11 ) 2013.11